Retinoids, Retinoic Acid Receptors, and Breast Cancer

References

• Wolbach S.B., Howe P.R. Tissue changes following deprivation of fat-soluble A vitamin. J. Exp. Med. 1925; 42: 753–778
   PubMedGoogle Scholar
• Hunter D.J., Manson J.E., Colditz G.A., Stampfer M.J., Rosner B., Hennekens C.H., Speizer F.E., Willett W.C. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N. Engl. J. Med. 1993; 329(4)234–240
   PubMed Web of Science ®Google Scholar
• Kushi L.H., Fee R.M., Sellers T.A., Zheng W., Folsom A.R. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am. J. Epidemiol. 1996; 144(2)165–174
   PubMed Web of Science ®Google Scholar
• Verhoeven D.T., Assen N., Goldbohm R.A., Dorant E., van't Veer P., Sturmans F., Hermus R.J., van den Brandt P.A. Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: a prospective cohort study. Br. J. Cancer 1997; 75(1)149–155
   PubMed Web of Science ®Google Scholar
• Ferguson L., Harris P. Protection against cancer by wheat bran: role of dietary fibre and phyochemicals. Eur. J. Cancer Prev. 1999; 8: 17–25
   PubMed Web of Science ®Google Scholar
• Messina M. Soy, soy phytoestrogens (isoflavones), and breast cancer. Am. J. Clin. Nutr. 1999; 70(4)574–575
   PubMed Web of Science ®Google Scholar
• Messina M.J. Legumes and soybeans: overview of their nutritional profiles and health effects. Am. J. Clin. Nutr. 1999; 70(3 Suppl.)439S–450S
   PubMed Web of Science ®Google Scholar
• Rose D., Connolly J., Liu X. Diet and breast cancer: opportunities for prevention and intervention. Ninth International Conference on Carcinogenesis and Risk Assessment. Wiley-Liss, Austin, TX 1995
   Google Scholar
• Moon R.C., Mehta R.G., Rao K.V.N. Retinoids and cancer in experimental animals. The Retinoids: Biology, Chemistry, and Medicine, M.B. Sporn, A.B. Roberts, D.S. Goodman. Raven, New York 1994; 573–595
   Google Scholar
• Moon R.C., Thompson H.J., Becci P.J., Grubbs C.J., Gander R.J., Newton D.L., Smith J.M., Phillips S.L., Henderson W.R., Mullen L.T., Brown C.C., Sporn M.B. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 1979; 39(4)1339–1346
   PubMed Web of Science ®Google Scholar
• McCormick D.L., Moon R.C. Influence of delayed administration of retinyl acetate on mammary carcinogenesis. Cancer Res. 1982; 42(7)2639–2643
   PubMed Web of Science ®Google Scholar
• Ratko T.A., Detrisac C.J., Dinger N.M., Thomas C.F., Kelloff G.J., Moon R.C. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res. 1989; 49(16)4472–4476
   PubMed Web of Science ®Google Scholar
• Anzano M.A., Byers S.W., Smith J.M., Peer C.W., Mullen L.T., Brown C.C., Roberts A.B., Sporn M.B. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res. 1994; 54(17)4614–4617
   PubMed Web of Science ®Google Scholar
• Anzano M.A., Peer C.W., Smith J.M., Mullen L.T., Shrader M.W., Logsdon D.L., Driver C.L., Brown C.C., Roberts A.B., Sporn M.B. Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. J. Natl Cancer Inst. 1996; 88(2)123–125
   PubMed Web of Science ®Google Scholar
• Agarwal V.R., Bischoff E.D., Hermann T., Lamph W.W. Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin). Cancer Res. 2000; 60(21)6033–6038
   PubMed Web of Science ®Google Scholar
• Bischoff E.D., Gottardis M.M., Moon T.E., Heyman R.A., Lamph W.W. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma. Cancer Res. 1998; 58(3)479–484
   PubMed Web of Science ®Google Scholar
• Treuting, P.M.; Chen, L.I.; Buetow, B.S.; Zeng, W.; Birkebak, T.; Seewaldt, V.L.; Sommer, K.M.; Emond, M.; Maggio-Price, L.; Swisshelm, K. Retinoic acid receptor B2 inhibition of metastasis in mouse mammary gland xenografts. Breast Cancer Res. Treat. in press.
   Google Scholar
• Budd G., Adamson P.C., Gupta M., Homayoun P., Sandstrom S.K., Murphy R.F., McLain D., Tuason L., Peereboom D., Bukowski R.M., Ganapathy R. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. Clin. Cancer Res. 1998; 4: 635–642
   PubMed Web of Science ®Google Scholar
• Toma S., Raffo P., Nicolo G., Canavese G., Margallo E., Vecchio C., Dastoli G., Iacona I., Regazzi-Bonora M. Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients. Int. J. Oncol. 2000; 17(5)991–1000
   PubMed Web of Science ®Google Scholar
• National Cancer Institute DCPC Chemoprevention Branch and Agent Development Committee Clinical development plan: vitamin A. J. Cell. Biochem. 1996, 26S, 269–307.
   Google Scholar
• Cobleigh M.A. Breast cancer and fenretinide, an analogue of vitamin A. Leukemia 1994; 8(Suppl. 3)S59–S63
   PubMedGoogle Scholar
• Veronesi U., De Palo G., Marubini E., Costa A., Formelli F., Mariani L., Decensi A., Camerini T., Del Turco M.R., Di Mauro M.G., Muraca M.G., Del Vecchio M., Pinto C., D'Aiuto G., Boni C., Campa T., Magni A., Miceli R., Perloff M., Malone W.F., Sporn M.B. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J. Natl Cancer Inst. 1999; 91(21)1847–1856
   PubMed Web of Science ®Google Scholar
• Conley B., O'Shaughnessy J., Prindiville S., Lawrence J., Chow C., Jones E., Merino M.J., Kaiser-Kupfer M.I., Caruso R.C., Podgor M., Goldspiel B., Venzon D., Danforth D., Wu S., Noone M., Goldstein J., Cowan K.H., Zujewski J. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer. J. Clin. Oncol. 2000; 18(2)275–283
   PubMed Web of Science ®Google Scholar
• Piantadosi S. Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?. J. Natl Cancer Inst. 1999; 91(21)1794
   PubMed Web of Science ®Google Scholar
• Sporn M.B., Suh N. Chemoprevention of cancer. Carcinogenesis 2000; 21(3)525–530
   PubMed Web of Science ®Google Scholar
• Blaner W.S., Piantadosi R., Sykes A., Vogel S. Retinoic acid synthesis and metabolism. Handbook Exp. Pharmacol. 1999; 139: 117–152
   Google Scholar
• Napoli J.L. Retinoic acid biosynthesis and metabolism. FASEB J. 1996; 10(9)993–1001
   PubMed Web of Science ®Google Scholar
• Vogel S., Gamble M.V., Blaner W.S. Biosynthesis, absorption, metabolism and transport of retinoids. Handbook Exp. Pharmacol. 1999; 139: 31–96
   Google Scholar
• Takatsuka J., Takahashi N., de Luca L.M. Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res. 1996; 56(4)675–678
   PubMed Web of Science ®Google Scholar
• Bhat P.V., Lacroix A. Metabolism of retinol and retinoic acid in N-methyl-N-nitrosourea-induced mammary carcinomas in rats. Cancer Res. 1989; 49(1)139–144
   PubMed Web of Science ®Google Scholar
• Chen A.C., Guo X., Derguini F., Gudas L.J. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol. Cancer Res. 1997; 57(20)4642–4651
   PubMed Web of Science ®Google Scholar
• Deng G., Lu Y., Zlotnikov G., Thor A.D., Smith H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996; 274(5295)2057–2059
   PubMed Web of Science ®Google Scholar
• Widschwendter M., Berger J., Daxenbichler G., Muller-Holzner E., Widschwendter A., Mayr A., Marth C., Zeimet A.G. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res. 1997; 57(19)4158–4161
   PubMed Web of Science ®Google Scholar
• Xu X.C., Sneige N., Liu X., Nandagiri R., Lee J.J., Lukmanji F., Hortobagyi G., Lippman S.M., Dhingra K., Lotan R. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res. 1997; 57(22)4992–4996
   PubMed Web of Science ®Google Scholar
• Lawrence J.A., Merino M.J., Simpson J.F., Manrow R.E., Page D.L., Steeg P.S. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Cancer Epidemiol. Biomarkers Prev. 1998; 7(1)29–35
   PubMed Web of Science ®Google Scholar
• Ariga N., Moriya T., Suzuki T., Kimura M., Ohuchi N., Sasano H. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast. Jpn. J. Cancer Res. 2000; 91(11)1169–1176
   PubMedGoogle Scholar
• Suzuki T., Moriya T., Sugawara A., Ariga N., Takabayashi H., Sasano H. Retinoid receptors in human breast carcinoma: possible modulators of in situ estrogen metabolism. Breast Cancer Res. Treat. 2001; 65(1)31–40
   PubMed Web of Science ®Google Scholar
• Sommer K.M., Chen L.I., Treuting P.M., Smith L.T., Swisshelm K. Elevated retinoic acid receptor beta(4) protein in human breast tumor cells with nuclear and cytoplasmic localization. Proc. Natl Acad. Sci. U.S.A. 1999; 96(15)8651–8656
   PubMed Web of Science ®Google Scholar
• Widschwendter M., Berger J., Hermann M., Muller H.M., Amberger A., Zeschnigk M., Widschwendter A., Abendstein B., Zeimet A.G., Daxenbichler G., Marth C. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J. Natl Cancer Inst. 2000; 92(10)826–832
   PubMed Web of Science ®Google Scholar
• Yang Q., Sakurai T., Yoshimura G., Mori I., Nakamura M., Nakamura Y., Suzuma T., Tamaki T., Umemura T., Kakudo K. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma. Anticancer Res. 2001; 21(3B)1829–1833
   PubMed Web of Science ®Google Scholar
• Yang Q., Mori I., Shan L., Nakamura M., Nakamura Y., Utsunomiya H., Yoshimura G., Suzuma T., Tamaki T., Umemura T., Sakurai T., Kakudo K. Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. Am. J. Pathol. 2001; 158(1)299–303
   PubMed Web of Science ®Google Scholar
• Krezel W., Kastner P., Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 1999; 89(4)1291–1300
   PubMed Web of Science ®Google Scholar
• Chen, L.I.; Sommer, K.M.; Swisshelm, K. A downstream translation start site in retinoic acid receptor beta-2 and -4 mRNA creates a protein isoform that disrupts retinoid-activated transcription, unpublished.
   Google Scholar
• Zimmer A., Zimmer A.M., Reynolds K. Tissue specific expression of the retinoic acid receptor-beta 2: regulation by short open reading frames in the 5′-noncoding region. J. Cell Biol. 1994; 127(4)1111–1119
   PubMed Web of Science ®Google Scholar
• Roman S.D., Clarke C.L., Hall R.E., Alexander I.E., Sutherland R.L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 1992; 52(8)2236–2242
   PubMed Web of Science ®Google Scholar
• Swisshelm K., Ryan K., Lee X., Tsou H.C., Peacocke M., Sager R. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ. 1994; 5(2)133–141
   PubMedGoogle Scholar
• Seewaldt V.L., Johnson B.S., Parker M.B., Collins S.J., Swisshelm K. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 1995; 6(9)1077–1088
   PubMedGoogle Scholar
• Liu Y., Lee M.O., Wang H.G., Li Y., Hashimoto Y., Klaus M., Reed J.C., Zhang X. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol. 1996; 16(3)1138–1149
   PubMed Web of Science ®Google Scholar
• Li Y., Hashimoto Y., Agadir A., Kagechika H., Zhang X. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells. J. Biol. Chem. 1999; 274(22)15360–15366
   PubMed Web of Science ®Google Scholar
• Seewaldt V.L., Caldwell L.E., Johnson B.S., Swisshelm K., Collins S.J., Tsai S. Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. Exp. Cell Res. 1997; 236(1)16–28
   PubMed Web of Science ®Google Scholar
• Roman S.D., Ormandy C.J., Manning D.L., Blamey R.W., Nicholson R.I., Sutherland R.L., Clarke C.L. Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res. 1993; 53(24)5940–5945
   PubMed Web of Science ®Google Scholar
• Sheikh M.S., Shao Z.M., Chen J.C., Hussain A., Jetten A.M., Fontana J.A. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell. Biochem. 1993; 53(4)394–404
   PubMed Web of Science ®Google Scholar
• van der Burg B., van der Leede B.M., Kwakkenbos-Isbrucker L., Salverda S., de Laat S.W., van der Saag P.T. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol. 1993; 91(1–2)149–157
   PubMed Web of Science ®Google Scholar
• van der Leede B.J., Folkers G.E., van den Brink C.E., van der Saag P.T., van der Burg B. Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol. Cell. Endocrinol. 1995; 109(1)77–86
   PubMed Web of Science ®Google Scholar
• Wickerham D.L., Tan-Chiu E. Breast cancer chemoprevention: current status and future directions. Semin. Oncol. 2001; 28(3)253–259
   PubMed Web of Science ®Google Scholar